Immunological Aspects in Late Phase of Living Donor Liver Transplant Patients: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity
Figure 3
IMK ATP levels and tacrolimus C/D ratio in patients with or without rejection. (a) (range 112–312) ng/mL and . (b) The ATP was 663.2 (range 569–709) ng/mL and 306.6 (range 146–615) ng/mL, respectively.
